APRECAP 125MG (Aprepitant (125mg) + Aprepitant (80mg))

APRECAP 125MG CAP is a medication commonly used to help manage nausea and vomiting that may occur after certain types of chemotherapy treatments. It supports patients by helping to alleviate these uncomfortable symptoms, which can often be a barrier to receiving necessary cancer treatment. By doing so, it aims to improve the overall experience of those undergoing chemotherapy.

Aprepitant, the active ingredient in APRECAP, works by blocking specific receptors in the brain that trigger nausea and vomiting. This action helps reduce the likelihood of these symptoms occurring, allowing patients to maintain better control over their condition during treatment.

For optimal results, it is generally recommended to store this medication in a cool, dry place, away from direct sunlight and moisture. Consistency in using the medication as directed may enhance its effectiveness. It is also important to inform your healthcare provider of any existing health conditions or medications you are taking, as this can help ensure safety and effectiveness.

Some common mild side effects may include fatigue, dizziness, or a slight headache. While these effects are generally not severe, it is essential to monitor any unusual symptoms and discuss them with a healthcare provider if they persist.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.